Literature DB >> 25297891

Dysmobility syndrome and mortality risk in US men and women age 50 years and older.

A C Looker1.   

Abstract

UNLABELLED: Mortality risk was significantly elevated in older adults from NHANES 1999-2002 with dysmobility syndrome.
INTRODUCTION: Dysmobility syndrome was recently proposed as an approach to evaluate the musculoskeletal health of older persons, but data linking this syndrome to adverse outcomes are currently lacking. The present study used data from the National Health and Nutrition Examination Survey (NHANES) 1999-2002 to assess the relationship between dysmobility and mortality in adults age 50 years and older by age, sex, and race or ethnicity.
METHODS: Dysmobility was defined as three or more of the following: high body fat, osteoporosis, low muscle mass, low muscle strength, slow gait speed, or falling risk. Body composition and bone density were assessed with dual energy X-ray absorptiometry. Gait speed was measured via a timed walk, muscle strength via isokinetic knee extension, and fall risk via self-reported balance problems in the past year. Hazard ratios (HRs) for mortality were calculated with Cox proportional hazard models.
RESULTS: Twenty-two percent of adults age 50+ years had dysmobility in 1999-2002. Mortality risk by dysmobility varied significantly by age (pinteraction = 0.001). HRs for those aged 50-69 years were 3.63 (95% confidence interval (CI) 2.69, 4.90) and 2.59 (95% CI 1.82, 3.69), respectively, before and after adjusting for all confounders, compared with 1.46 (95% CI 1.07, 1.99) and 1.23 (95% CI 0.89, 1.69) for those aged 70+ years. The relationship was significant when examined by sex or race/ethnicity within age group for most subgroups.
CONCLUSIONS: Dysmobility was associated with increased mortality risk in adults age 50 years and older, with risk being higher in those age 50-69 years than in those age 70+ years.

Entities:  

Mesh:

Year:  2014        PMID: 25297891      PMCID: PMC4757903          DOI: 10.1007/s00198-014-2904-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  21 in total

1.  Simulation study of the effect of the early mortality exclusion on confounding of the exposure-mortality relation by preexisting disease.

Authors:  P N Singh; X Wang
Journal:  Am J Epidemiol       Date:  2001-11-15       Impact factor: 4.897

2.  Simulation study of the effects of excluding early deaths on risk factor-mortality analyses in the presence of confounding due to occult disease: the example of body mass index.

Authors:  D B Allison; M Heo; D W Flanders; M S Faith; K M Carpenter; D F Williamson
Journal:  Ann Epidemiol       Date:  1999-02       Impact factor: 3.797

3.  Osteoporosis assessment by whole body region vs. site-specific DXA.

Authors:  L Joseph Melton; Anne C Looker; John A Shepherd; Michael K O'Connor; Sara J Achenbach; B Lawrence Riggs; Sundeep Khosla
Journal:  Osteoporos Int       Date:  2005-04-06       Impact factor: 4.507

4.  Epidemiology of sarcopenia among the elderly in New Mexico.

Authors:  R N Baumgartner; K M Koehler; D Gallagher; L Romero; S B Heymsfield; R R Ross; P J Garry; R D Lindeman
Journal:  Am J Epidemiol       Date:  1998-04-15       Impact factor: 4.897

5.  Explained variation in survival analysis.

Authors:  M Schemper; J Stare
Journal:  Stat Med       Date:  1996-10-15       Impact factor: 2.373

Review 6.  Elevated body mass index and mortality risk in the elderly.

Authors:  I Janssen; A E Mark
Journal:  Obes Rev       Date:  2007-01       Impact factor: 9.213

7.  The diagnosis of osteoporosis.

Authors:  J A Kanis; L J Melton; C Christiansen; C C Johnston; N Khaltaev
Journal:  J Bone Miner Res       Date:  1994-08       Impact factor: 6.741

8.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

9.  Isokinetic and isometric muscle strength in a healthy population with special reference to age and gender.

Authors:  B Danneskiold-Samsøe; E M Bartels; P M Bülow; H Lund; A Stockmarr; C C Holm; I Wätjen; M Appleyard; H Bliddal
Journal:  Acta Physiol (Oxf)       Date:  2009-10       Impact factor: 6.311

10.  Isokinetic leg muscle strength in older americans and its relationship to a standardized walk test: data from the national health and nutrition examination survey 1999-2000.

Authors:  Yechiam Ostchega; Charles F Dillon; Rosemary Lindle; Margaret Carroll; Ben F Hurley
Journal:  J Am Geriatr Soc       Date:  2004-06       Impact factor: 5.562

View more
  15 in total

1.  Dysmobility Syndrome Independently Increases Fracture Risk in the Osteoporotic Fractures in Men (MrOS) Prospective Cohort Study.

Authors:  Bjoern Buehring; Karen E Hansen; Brian L Lewis; Steven R Cummings; Nancy E Lane; Neil Binkley; Kristine E Ensrud; Peggy M Cawthon
Journal:  J Bone Miner Res       Date:  2018-06-21       Impact factor: 6.741

2.  Automated Muscle Measurement on Chest CT Predicts All-Cause Mortality in Older Adults From the National Lung Screening Trial.

Authors:  Leon Lenchik; Ryan Barnard; Robert D Boutin; Stephen B Kritchevsky; Haiying Chen; Josh Tan; Peggy M Cawthon; Ashley A Weaver; Fang-Chi Hsu
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-01-18       Impact factor: 6.053

3.  Low peak jump power is associated with elevated odds of dysmobility syndrome in community-dwelling elderly individuals: the Korean Urban Rural Elderly (KURE) study.

Authors:  Namki Hong; Chang Oh Kim; Yoosik Youm; Hyeon Chang Kim; Yumie Rhee
Journal:  Osteoporos Int       Date:  2018-03-08       Impact factor: 4.507

4.  Association between dietary inflammatory index score and muscle mass and strength in older adults: a study from National Health and Nutrition Examination Survey (NHANES) 1999-2002.

Authors:  Jingjing Ming; Lingzhi Chen; Tianyi Chen; James R Hébert; Peng Sun; Li Zhang; Hongya Wang; Qingkuo Wu; Cancan Zhang; Nitin Shivappa; Bo Ban
Journal:  Eur J Nutr       Date:  2022-07-09       Impact factor: 5.614

5.  The diagnostic value of phase angle, an integrative bioelectrical marker, for identifying individuals with dysmobility syndrome: the Korean Urban-Rural Elderly study.

Authors:  Y W Jung; N Hong; C O Kim; H C Kim; Y Youm; J -Y Choi; Y Rhee
Journal:  Osteoporos Int       Date:  2020-10-30       Impact factor: 4.507

6.  Definitions of Sarcopenia: Associations with Previous Falls and Fracture in a Population Sample.

Authors:  M A Clynes; M H Edwards; B Buehring; E M Dennison; N Binkley; C Cooper
Journal:  Calcif Tissue Int       Date:  2015-07-30       Impact factor: 4.333

Review 7.  Dysmobility syndrome: current perspectives.

Authors:  Keith D Hill; Kaela Farrier; Melissa Russell; Elissa Burton
Journal:  Clin Interv Aging       Date:  2017-01-16       Impact factor: 4.458

8.  Dysmobility Syndrome and Risk of Mortality for Community-Dwelling Middle-Aged and Older Adults: The Nexus of Aging and Body Composition.

Authors:  Wei-Ju Lee; Li-Kuo Liu; An-Chun Hwang; Li-Ning Peng; Ming-Hsien Lin; Liang-Kung Chen
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

9.  Exploring the link between metabolic syndrome and risk of dysmobility syndrome in elderly population.

Authors:  Yuan-Yuei Chen; Tung-Wei Kao; Chung-Ching Wang; Ying-Jen Chen; Chen-Jung Wu; Wei-Liang Chen
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

Review 10.  Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia.

Authors:  Kyoung Min Kim; Hak Chul Jang; Soo Lim
Journal:  Korean J Intern Med       Date:  2016-06-22       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.